IntROdUctIOn
C a r b a p e n e m -h y d r o l y s i n g β-lactamases such as carbapenemases in bacterial clinical isolates are of increasing concern, that's because they often also confer resistance to most other β-lactam antimicrobial agents (1) . Metallo-β-lactamases (MBLs), as one class of carbapenemases, which belongs to ambler class B metallo-enzyme groups, plays an important role in the multidrug resistance of Enterobacteriaceae. In the past, the prevalence of MBLs producing clinical isolat (s was increasing worldwide, and most of the MBL-encoding genes such as bla IMP and bla VIM etc. reside on class 1 integrons and plasmids that usually confer high mobility to these genetic elements (2, 3, 4, 5) . Therefore, early detection of MBL-producing organisms is of crucial importance for prevention of their inter-and intrahospital dissemination, not only in institutions with high prevalences of such isolates but also in those in which phenotypes of resistance have never been detected (6) .
Recently, a new class B enzyme, New Delhi metallo-β-lactamase (NDM-1), as a broad-spectrum β-lactamase, which is able to inactivate all β-lactams except aztreonam (7) . Since the first report of NDM-producing Klebsiella pneumoniae from Sweden in December 2009 (7) , NDM-producers have been detected in extensive pathogen all over the world (8, 9, 10, 11) . Especially, the NDM-1 not only harbored in Enterobacteriaceae isolates, but also have been detected in Enterococcus (12) . NDM-1 producers bring several additional factors such as high mobility, spreading producers, and the host-pathogen pathogenicity, which are deeply disconcerting for public health worldwide (13) . Therefore, there is an urgent international need to rapid detect NDM-1 producers in any health care facility to prevent their futher spread.
Various criteria for screening MBL-producers have been suggested (6, 14) , such as Etest MBL strip (15) , double-disk synergy test (DDST) and combined disk (CD) assay (6), of which the susceptibility testing results were recorded according to the Clinical and Laboratory Standards Institute (CLSI) guidelines as modified in June 2010 (16) . However, such methods are time-consuming and don't discriminate between NDM-1 and other MBLs. So the detection of the bla NDM-1 gene based on PCR and real-time PCR molecular techniques are rapid methods to screening and identifying the carriers of NDM-1 producers (13, 17) . At present, the PCR and real-time PCR techniques are always established based on a certain sequence from a certain bacteria strain, some other strains may be escaped from the screening and detecting of NDM-1 producers.
The aim of this study was to evaluate the homology of bla NDM-1 gene from Enterobacteriaceae and Enterococcus, and find out the common sequence of bla NDM-1 gene from different host-pathogen for the subsequent PCR and real-time PCR detection.
MAtERIALS And MEtHOdS
The source of NDM-1 gene seReview SuMMarY New delhi metallo-β-lactamase (NdM-1), as a broad-spectrum β-lactamase, is able to inactivate almost all β-lactams. NdMproducers have been detected in extensively pathogen worldwide. the objective of this study was to analyze the homology of NdM-1-encoding genes based on the blaNdM-1 gene sequences downloaded from genBank. the phylogenetic tree analysis showed that the blaNdM-1 gene sequences divided into two different branches with similarity score only 54. a common sequence of 242bps at length was extracted from branch-1, and 469bps common sequence was extracted from branch-2, respectively. the subsequent detection of NdM-1 harboring clinical isolates with PCr and real-time PCr molecularquences. We searched the GenBank database in National Center of Biotechnology Information (NCBI) website (http://www.ncbi.nlm.niv. gov) with search term of "NDM-1", and got the NDM-1 sequences from variety of Enterobacteriaceae and Enterococcus submitted before August 1, 2011.
Sequences analysis. The NDM-1 sequences were contrasted with biosoftware Clustal W2 provided by European Molecular Biology Laboratory (http://www.ebi.ac.uk/Tools/ clustalw2/index.html?). The phylogenetic tree was established to study the characteristics of the NDM-1 sequences. The similarity scores were analyzed and the common sequence was also extracted.
RESULtS

Total homology analysis of bla NDM-1 genes
We have extracted 23 bla NDM-1 gene sequences from NDM-1-harboring clinical isolates, of which 9 for Klebsiella pneumoniae, 6 for Escherichia coli, 4 for Acinetobacter baumannii, 2 for Pseudomonas aeruginosa, one for Stenotrophomonas maltophilia and Enterococcus faecium (showed in Table 1 ). The totle homology of these 23 bla NDM-1 gene sequences showed that there have sourced from two different branches respectively (Figure 1a) , we called branch-1 and branch-2. Branch-1 including 18 sequences with the accession number of HQ328085,  AB604953, AB604954, HQ284042,  JF838352, HQ284043, HQ605724,  JN157767, FR820590, FR820591,  JF922606, HQ451074, HQ917683,  HQ652608, JF836807, AB614355,  HQ256747 and AB571289. While  branch-2 including 5 sequences: HQ171206, HQ652609, HQ738352, HQ162469 and FN396876. The similarity scores in branch-1 were from 60 to 100, most of which were 99 and 100, while in branch-2, all the similar scores were 100. However, the similarity scores between branch-1 and branch-2 just from 43 to 54 (Figure 1b) .
The sequences characteristics of branch-1 and branch-2
The sequences contrasting analysis of branch-1 and branch-2 have 51  43  43  43  49  100  44  44  100   HQ171206   43  51  50  51  40  100  51  52  100  100  AB614355 100  100  100  100  100  43  100  100  43  43  51  FR820591 100  100  100  100  100  49  100  100  49  49  54  100  FR820590 100  100  100  100  100  49  100  100  49  49  54  100 been processed respectively, and the results of contrasting analysis showed in Supplementary Figure  S1 and Figure S2 . We have extracted a common sequence at length of 242bp from branch-1 (Figure 2 ), and the common sequence positions showed in Table 2 . A 469bp common sequence has been extracted from branch-2 ( Figure 3 ), the positions of common sequence showed in Table 3 . The similarity between the common sequences of branch-1 and branch-2 have also contrasted, and the score only 54 (showed in Supplementary Figure S3 ).
dIScUSSIOn
Carbapenemase-expressing Enterobacteriaceae and Enterococcus are of great threat to the global health system, that's because this class of antibiotics is of major importance as a last-line therapy of nosocomial infections (17) . The emergence of the novel carbapenemase, NDM-1, was widely noticed and even reported by popular media, and the prevalence of NDM-1 producing strains have made the medical staff feeling worrisome. To present, the bla NDM-1 -harboring strains have been detected in multiple areas: India (18, 19) , China (20) , United States (21), Japan (22, 23) , Singapore (24) , Canada (25, 26) , Australia (27) Table 1 ). So it is need to analyse the homology for the epidemiological study. Our study showed that there are two branches of bla NDM-1 encoding gene in NDM-1 producing pathogen. In some countries with great population such as India and China, both branches were detected, while in the country of small populations such as Japan, Singapore and Serbia, just one branch was detected. In addition, in some other countries such as France, Malaysia, Australia, Spain, and Canada, just one clinical isolate reported at present.
PCR and real-time PCR techniques are regarded as rapid methods in molecular diagnostics, and the real-time PCR may represent the current gold standard. The use of synthetic gene as positive control reaction demonstrates that the PCR assay works are functional, however, there might still have a false-negative result because the PCR and real-time PCR techniques are processed based on a certain sequence from a certain strain. That made some other strains which only single or several bases different from the certain sequence escaped from screening and detecting. The results of this study demonstrated that there are two branches with low similarity in bla NDM-1 , that's to say we should establish the PCR and realtime PCR techniques based on these two common sequences of branch-1 and branch-2 to increase the detect- Sequence number used in this study accession number in genBank  sequence1  HQ605724  sequence2  HQ256747  sequence3  HQ917683  sequence4  HQ451074  sequence5  aB571289  sequence6  HQ162469  sequence7  HQ284043  sequence8  HQ284042  sequence9  FN396876  sequence10  HQ738352  sequence11  HQ171206  sequence12  aB614355  sequence13  Fr820591  sequence14  Fr820590  sequence15  JN157767  sequence16  JF838352  sequence17  HQ652609  sequence18  HQ652608  sequence19  aB604954  sequence20  aB604953  sequence21  JF922606  sequence22  JF836807  sequence23  HQ328085   sequence24 Common sequence of branch-1 sequence25 Common sequence of branch-2 The common sequence is emphasized with "*".
CLUSTAL 2.1 multiple sequence alignment sequence5 sequence8 CTGGTGGTCGATACCGCCTGGACCGATGACCAGACCGCCCAGATCCTCAACTGGATCAAG 246 ************************************************************ CAGGAGATCAACCTGCCGGTCGCGCTGGCGGTGGTGACTCACGCGCATCAGGACAAGATG 306 ************************************************************ GGCGGTATGGACGCGCTGCATGCGGCGGGGATTGCGACTTATGCCAATGCGTTGTCGAAC 366 ************************************************************ CAGCTTGCCCCGCAAGAGGGGATGGTTGCGGCGCAACACAGCCTGACTTTC---------417 *************************************************** GGCTGCCTGATCAAGGACAGCAAGGCCAAGTCGCTCGGCAATCTCGGTGATGCCGACACT 634 GTGATGAGCCATTCCGCCCCCGATAGCCGCGCCGCAATCACT sequence6  TCAGCGCAGCTTGTCGGCCATGCGGGCCGTATGAGTGATTGCGGCGCGGCTATCGGGGGC 60  sequence9  TCAGCGCAGCTTGTCGGCCATGCGGGCCGTATGAGTGATTGCGGCGCGGCTATCGGGGGC 60  sequence10  TCAGCGCAGCTTGTCGGCCATGCGGGCCGTATGAGTGATTGCGGCGCGGCTATCGGGGGC 60  sequence17 -
sequence1 -----------------------------------------------------------
sequence1 ------------------------------------------------------------
CGCGGCGTAGTGCTCAGTGTCGGCATCACCGAGATTGCCGAGCGACTTGGCCTTGCTGTC 180 sequence10 CGCGGCGTAGTGCTCAGTGTCGGCATCACCGAGATTGCCGAGCGACTTGGCCTTGCTGTC 180 sequence17 CGCGGCGTAGTGCTCAGTGTCGGCATCACCGAGATTGCCGAGCGACTTGGCCTTGCTGTC 80 sequence11
-------------TCAGTGTCGGCATCACCGAGATTGCCGAGCGACTTGGCCTTGCTGTC 47 *********************************************** sequence6 CTTGATCAGGCAGCCACCAAAAGCGATGTCGGTGCCGTCGATCCCAACGGTGATATTGTC 240 sequence9 CTTGATCAGGCAGCCACCAAAAGCGATGTCGGTGCCGTCGATCCCAACGGTGATATTGTC 240 sequence10 CTTGATCAGGCAGCCACCAAAAGCGATGTCGGTGCCGTCGATCCCAACGGTGATATTGTC 240 sequence17 CTTGATCAGGCAGCCACCAAAAGCGATGTCGGTGCCGTCGATCCCAACGGTGATATTGTC 140 sequence11 CTTGATCAGGCAGCCACCAAAAGCGATGTCGGTGCCGTCGATCCCAACGGTGATATTGTC 107 ************************************************************ sequence6 ACTGGTGTGGCCGGGGCCGGGGTAAAATACCTTGAGCGGGCCAAAGTTGGGCGCGGTTGC 300 sequence9 ACTGGTGTGGCCGGGGCCGGGGTAAAATACCTTGAGCGGGCCAAAGTTGGGCGCGGTTGC 300 sequence10 ACTGGTGTGGCCGGGGCCGGGGTAAAATACCTTGAGCGGGCCAAAGTTGGGCGCGGTTGC 300 sequence17 ACTGGTGTGGCCGGGGCCGGGGTAAAATACCTTGAGCGGGCCAAAGTTGGGCGCGGTTGC 200 sequence11 ACTGGTGTGGCCGGGGCCGGGGTAAAATACCTTGAGCGGGCCAAAGTTGGGCGCGGTTGC 167 ************************************************************ sequence6  TGGTTCGACCCAGCCATTGGCGGCGAAAGTCAGGCTGTGTTGCGCCGCAACCATCCCCTC 360  sequence9  TGGTTCGACCCAGCCATTGGCGGCGAAAGTCAGGCTGTGTTGCGCCGCAACCATCCCCTC 360  sequence10  TGGTTCGACCCAGCCATTGGCGGCGAAAGTCAGGCTGTGTTGCGCCGCAACCATCCCCTC 360  sequence17  TGGTTCGACCCAGCCATTGGCGGCGAAAGTCAGGCTGTGTTGCGCCGCAACCATCCCCTC 260  sequence11 TGGTTCGACCCAGCCATTGGCGGCGAAAGTCAGGCTGTGTTGCGCCGCAACCATCCCCTC 227 ************************************************************ GATTTCACCGGGCATGCACCCGCTCAGCATCAATGCAGCGGCTAATGCGGTGCTCAGCTT 780 sequence17 TTGCGGGGCAAGCTGGTTCGACAACGCATTGGCATAAGTCGCAATCCCCGCCGCATGCAG 287 ************************************************************ CGCGTCCATACCGCCCATCTTGTCCTGATGCGCGTGAGTCACCACCGCCAGCGCGACCGG 347 ************************************************************ CAGGTTGATCTCCTGCTTGATCCAGTTGAGGATCTGGGCGGTCTGGTCATCGGTCCAGGC 407 ************************************************************ sequence6 GGTATCGACCACCAGCACGCGGCCGCCATCCCTGACGATCAAACCGTTGGAAGCGACTGC 600 sequence9 GGTATCGACCACCAGCACGCGGCCGCCATCCCTGACGATCAAACCGTTGGAAGCGACTGC 600 sequence10 GGTATCGACCACCAGCACGCGGCCGCCATCCCTGACGATCAAACCGTTGGAAGCGACTGC 600 sequence17 GGTATCGACCACCAGCACGCGGCCGCCATCCCTGACGATCAAACCGTTGGAAGCGACTGC 500 sequence11 GGTATCGACCACCAGCACGCGGCCGCCATCCCTGACGATCAAACCGTTGGAAGCGACTGC 467 ************************************************************ ****** :** common sequences of this study as a rapid detection and identification methods to control the hospital infection and the spreading of these resistant determinants. After the rapid detection, the DDST, CD assay and Etest MBL strip can be used for the identification of MBLs with negative isolates screened by PCR and real-time PCR to identify the false-negative bla NDM-1 harboring isolates.
